Merck’s (NYSE:MRK) monoclonal antibody clesrovimab, designed as a prophylactic against respiratory syncytial virus (RSV), has ...

Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren ...

Health experts highlight how this highly contagious disease affects vulnerable populations and share insights on prevention ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

Flu, COVID-19 and RSV are predicted to cause about as many hospitalizations as last year. Houston experts offer tips for ...

GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV ...

A team of researchers has identified signs tied to more severe cases of respiratory syncytial virus (RSV) in children.

For the next few months, cases of COVID-19, flu and respiratory syncytial virus, or RSV, are expected to rise as people gather indoors for the holidays. Infectious disease experts say October is ...

(WKRG) — More RSV cases are being reported in Mobile. It’s something you may not think much about unless you have children, but adults can get this potentially deadly respiratory virus ...